SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-187596
Filing Date
2013-04-30
Accepted
2013-04-30 16:46:39
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d516381d10q.htm 10-Q 475222
2 EX-21.1 d516381dex211.htm EX-21.1 2747
3 EX-31.1 d516381dex311.htm EX-31.1 6039
4 EX-31.2 d516381dex312.htm EX-31.2 5993
5 EX-32.1 d516381dex321.htm EX-32.1 3486
6 EX-32.2 d516381dex322.htm EX-32.2 3471
  Complete submission text file 0001193125-13-187596.txt   2882415

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idix-20130331.xml EX-101.INS 285493
8 XBRL TAXONOMY EXTENSION SCHEMA idix-20130331.xsd EX-101.SCH 34721
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idix-20130331_cal.xml EX-101.CAL 41640
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idix-20130331_def.xml EX-101.DEF 170048
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idix-20130331_lab.xml EX-101.LAB 250470
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idix-20130331_pre.xml EX-101.PRE 202475
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 13798341
SIC: 2834 Pharmaceutical Preparations